Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPOCAMP
NCT07054359Recruiting
- Sponsor
- ANRS
- Start
- Aug 2026
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tenofovir disoproxil fumarate in hepatitis B virus infection (2 arms), sponsored by ANRS. Primary endpoint: Percentage of HBsAg-positive women with HBV DNA <200,000 IU/mL. Started Aug 2026; status: recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B virus infection
Beyond the preview
Go deeper on NCT07054359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07054359.